Skip to main content
Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
31.62
+0.36 (1.15%)
At close: Apr 28, 2026, 4:00 PM EDT
31.85
+0.23 (0.73%)
After-hours: Apr 28, 2026, 7:58 PM EDT

Teva Pharmaceutical Revenue

In the year 2025, Teva Pharmaceutical had annual revenue of $17.26B with 4.32% growth. Teva Pharmaceutical had revenue of $4.71B in the quarter ending December 31, 2025, with 11.40% growth.

Revenue (ttm)
$17.26B
Revenue Growth
+4.32%
P/S Ratio
2.13
Revenue / Employee
$508,336
Employees
33,950
Market Cap
36.82B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202517.26B714.00M4.32%
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Takeda Pharmaceutical Company 28.48B
Haleon 14.85B
Viatris 14.30B
Zoetis 9.47B
Elanco Animal Health 4.72B
Dr. Reddy's Laboratories 3.85B
United Therapeutics 3.18B
Neurocrine Biosciences 2.86B
Revenue Rankings

TEVA News

More News